img

Global Osteoarthritis Gene Therapy Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Osteoarthritis Gene Therapy Market Research Report 2024

According to MRAResearch’s new survey, global Osteoarthritis Gene Therapy market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Osteoarthritis Gene Therapy market research.
Key companies engaged in the Osteoarthritis Gene Therapy industry include Flexion, GeneQuine, Novartis, Smith & Nephew, Genascence, Kolon TissueGene, Sanofi, Paraxel and Medipost, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Osteoarthritis Gene Therapy were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Osteoarthritis Gene Therapy market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Osteoarthritis Gene Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Flexion
GeneQuine
Novartis
Smith & Nephew
Genascence
Kolon TissueGene
Sanofi
Paraxel
Medipost
Mundipharma
Segment by Type
Synovium Injection
Cartilage Injection

Segment by Application


Hospitals and clinics
Orthopedic Centers
Assisted living Facilities
Nursing Homes
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Osteoarthritis Gene Therapy report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Osteoarthritis Gene Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Synovium Injection
1.2.3 Cartilage Injection
1.3 Market by Application
1.3.1 Global Osteoarthritis Gene Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals and clinics
1.3.3 Orthopedic Centers
1.3.4 Assisted living Facilities
1.3.5 Nursing Homes
1.3.6 Ambulatory Surgical Centers
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Osteoarthritis Gene Therapy Market Perspective (2018-2033)
2.2 Osteoarthritis Gene Therapy Growth Trends by Region
2.2.1 Global Osteoarthritis Gene Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Osteoarthritis Gene Therapy Historic Market Size by Region (2018-2023)
2.2.3 Osteoarthritis Gene Therapy Forecasted Market Size by Region (2024-2033)
2.3 Osteoarthritis Gene Therapy Market Dynamics
2.3.1 Osteoarthritis Gene Therapy Industry Trends
2.3.2 Osteoarthritis Gene Therapy Market Drivers
2.3.3 Osteoarthritis Gene Therapy Market Challenges
2.3.4 Osteoarthritis Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Osteoarthritis Gene Therapy Players by Revenue
3.1.1 Global Top Osteoarthritis Gene Therapy Players by Revenue (2018-2023)
3.1.2 Global Osteoarthritis Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Osteoarthritis Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Osteoarthritis Gene Therapy Revenue
3.4 Global Osteoarthritis Gene Therapy Market Concentration Ratio
3.4.1 Global Osteoarthritis Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Osteoarthritis Gene Therapy Revenue in 2022
3.5 Osteoarthritis Gene Therapy Key Players Head office and Area Served
3.6 Key Players Osteoarthritis Gene Therapy Product Solution and Service
3.7 Date of Enter into Osteoarthritis Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Osteoarthritis Gene Therapy Breakdown Data by Type
4.1 Global Osteoarthritis Gene Therapy Historic Market Size by Type (2018-2023)
4.2 Global Osteoarthritis Gene Therapy Forecasted Market Size by Type (2024-2033)
5 Osteoarthritis Gene Therapy Breakdown Data by Application
5.1 Global Osteoarthritis Gene Therapy Historic Market Size by Application (2018-2023)
5.2 Global Osteoarthritis Gene Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Osteoarthritis Gene Therapy Market Size (2018-2033)
6.2 North America Osteoarthritis Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Osteoarthritis Gene Therapy Market Size by Country (2018-2023)
6.4 North America Osteoarthritis Gene Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Osteoarthritis Gene Therapy Market Size (2018-2033)
7.2 Europe Osteoarthritis Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Osteoarthritis Gene Therapy Market Size by Country (2018-2023)
7.4 Europe Osteoarthritis Gene Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Osteoarthritis Gene Therapy Market Size (2018-2033)
8.2 Asia-Pacific Osteoarthritis Gene Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Osteoarthritis Gene Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Osteoarthritis Gene Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Osteoarthritis Gene Therapy Market Size (2018-2033)
9.2 Latin America Osteoarthritis Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Osteoarthritis Gene Therapy Market Size by Country (2018-2023)
9.4 Latin America Osteoarthritis Gene Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Osteoarthritis Gene Therapy Market Size (2018-2033)
10.2 Middle East & Africa Osteoarthritis Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Osteoarthritis Gene Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Osteoarthritis Gene Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Flexion
11.1.1 Flexion Company Detail
11.1.2 Flexion Business Overview
11.1.3 Flexion Osteoarthritis Gene Therapy Introduction
11.1.4 Flexion Revenue in Osteoarthritis Gene Therapy Business (2018-2023)
11.1.5 Flexion Recent Development
11.2 GeneQuine
11.2.1 GeneQuine Company Detail
11.2.2 GeneQuine Business Overview
11.2.3 GeneQuine Osteoarthritis Gene Therapy Introduction
11.2.4 GeneQuine Revenue in Osteoarthritis Gene Therapy Business (2018-2023)
11.2.5 GeneQuine Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Osteoarthritis Gene Therapy Introduction
11.3.4 Novartis Revenue in Osteoarthritis Gene Therapy Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Smith & Nephew
11.4.1 Smith & Nephew Company Detail
11.4.2 Smith & Nephew Business Overview
11.4.3 Smith & Nephew Osteoarthritis Gene Therapy Introduction
11.4.4 Smith & Nephew Revenue in Osteoarthritis Gene Therapy Business (2018-2023)
11.4.5 Smith & Nephew Recent Development
11.5 Genascence
11.5.1 Genascence Company Detail
11.5.2 Genascence Business Overview
11.5.3 Genascence Osteoarthritis Gene Therapy Introduction
11.5.4 Genascence Revenue in Osteoarthritis Gene Therapy Business (2018-2023)
11.5.5 Genascence Recent Development
11.6 Kolon TissueGene
11.6.1 Kolon TissueGene Company Detail
11.6.2 Kolon TissueGene Business Overview
11.6.3 Kolon TissueGene Osteoarthritis Gene Therapy Introduction
11.6.4 Kolon TissueGene Revenue in Osteoarthritis Gene Therapy Business (2018-2023)
11.6.5 Kolon TissueGene Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Osteoarthritis Gene Therapy Introduction
11.7.4 Sanofi Revenue in Osteoarthritis Gene Therapy Business (2018-2023)
11.7.5 Sanofi Recent Development
11.8 Paraxel
11.8.1 Paraxel Company Detail
11.8.2 Paraxel Business Overview
11.8.3 Paraxel Osteoarthritis Gene Therapy Introduction
11.8.4 Paraxel Revenue in Osteoarthritis Gene Therapy Business (2018-2023)
11.8.5 Paraxel Recent Development
11.9 Medipost
11.9.1 Medipost Company Detail
11.9.2 Medipost Business Overview
11.9.3 Medipost Osteoarthritis Gene Therapy Introduction
11.9.4 Medipost Revenue in Osteoarthritis Gene Therapy Business (2018-2023)
11.9.5 Medipost Recent Development
11.10 Mundipharma
11.10.1 Mundipharma Company Detail
11.10.2 Mundipharma Business Overview
11.10.3 Mundipharma Osteoarthritis Gene Therapy Introduction
11.10.4 Mundipharma Revenue in Osteoarthritis Gene Therapy Business (2018-2023)
11.10.5 Mundipharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Osteoarthritis Gene Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Synovium Injection
Table 3. Key Players of Cartilage Injection
Table 4. Global Osteoarthritis Gene Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Osteoarthritis Gene Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Osteoarthritis Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Osteoarthritis Gene Therapy Market Share by Region (2018-2023)
Table 8. Global Osteoarthritis Gene Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Osteoarthritis Gene Therapy Market Share by Region (2024-2033)
Table 10. Osteoarthritis Gene Therapy Market Trends
Table 11. Osteoarthritis Gene Therapy Market Drivers
Table 12. Osteoarthritis Gene Therapy Market Challenges
Table 13. Osteoarthritis Gene Therapy Market Restraints
Table 14. Global Osteoarthritis Gene Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Osteoarthritis Gene Therapy Market Share by Players (2018-2023)
Table 16. Global Top Osteoarthritis Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Gene Therapy as of 2022)
Table 17. Ranking of Global Top Osteoarthritis Gene Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Osteoarthritis Gene Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Osteoarthritis Gene Therapy Product Solution and Service
Table 21. Date of Enter into Osteoarthritis Gene Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Osteoarthritis Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Osteoarthritis Gene Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Osteoarthritis Gene Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Osteoarthritis Gene Therapy Revenue Market Share by Type (2024-2033)
Table 27. Global Osteoarthritis Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Osteoarthritis Gene Therapy Revenue Market Share by Application (2018-2023)
Table 29. Global Osteoarthritis Gene Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Osteoarthritis Gene Therapy Revenue Market Share by Application (2024-2033)
Table 31. North America Osteoarthritis Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Osteoarthritis Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Osteoarthritis Gene Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Osteoarthritis Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Osteoarthritis Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Osteoarthritis Gene Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Osteoarthritis Gene Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Osteoarthritis Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Osteoarthritis Gene Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Osteoarthritis Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Osteoarthritis Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Osteoarthritis Gene Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Osteoarthritis Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Osteoarthritis Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Osteoarthritis Gene Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 46. Flexion Company Detail
Table 47. Flexion Business Overview
Table 48. Flexion Osteoarthritis Gene Therapy Product
Table 49. Flexion Revenue in Osteoarthritis Gene Therapy Business (2018-2023) & (US$ Million)
Table 50. Flexion Recent Development
Table 51. GeneQuine Company Detail
Table 52. GeneQuine Business Overview
Table 53. GeneQuine Osteoarthritis Gene Therapy Product
Table 54. GeneQuine Revenue in Osteoarthritis Gene Therapy Business (2018-2023) & (US$ Million)
Table 55. GeneQuine Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis Osteoarthritis Gene Therapy Product
Table 59. Novartis Revenue in Osteoarthritis Gene Therapy Business (2018-2023) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Smith & Nephew Company Detail
Table 62. Smith & Nephew Business Overview
Table 63. Smith & Nephew Osteoarthritis Gene Therapy Product
Table 64. Smith & Nephew Revenue in Osteoarthritis Gene Therapy Business (2018-2023) & (US$ Million)
Table 65. Smith & Nephew Recent Development
Table 66. Genascence Company Detail
Table 67. Genascence Business Overview
Table 68. Genascence Osteoarthritis Gene Therapy Product
Table 69. Genascence Revenue in Osteoarthritis Gene Therapy Business (2018-2023) & (US$ Million)
Table 70. Genascence Recent Development
Table 71. Kolon TissueGene Company Detail
Table 72. Kolon TissueGene Business Overview
Table 73. Kolon TissueGene Osteoarthritis Gene Therapy Product
Table 74. Kolon TissueGene Revenue in Osteoarthritis Gene Therapy Business (2018-2023) & (US$ Million)
Table 75. Kolon TissueGene Recent Development
Table 76. Sanofi Company Detail
Table 77. Sanofi Business Overview
Table 78. Sanofi Osteoarthritis Gene Therapy Product
Table 79. Sanofi Revenue in Osteoarthritis Gene Therapy Business (2018-2023) & (US$ Million)
Table 80. Sanofi Recent Development
Table 81. Paraxel Company Detail
Table 82. Paraxel Business Overview
Table 83. Paraxel Osteoarthritis Gene Therapy Product
Table 84. Paraxel Revenue in Osteoarthritis Gene Therapy Business (2018-2023) & (US$ Million)
Table 85. Paraxel Recent Development
Table 86. Medipost Company Detail
Table 87. Medipost Business Overview
Table 88. Medipost Osteoarthritis Gene Therapy Product
Table 89. Medipost Revenue in Osteoarthritis Gene Therapy Business (2018-2023) & (US$ Million)
Table 90. Medipost Recent Development
Table 91. Mundipharma Company Detail
Table 92. Mundipharma Business Overview
Table 93. Mundipharma Osteoarthritis Gene Therapy Product
Table 94. Mundipharma Revenue in Osteoarthritis Gene Therapy Business (2018-2023) & (US$ Million)
Table 95. Mundipharma Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Osteoarthritis Gene Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Osteoarthritis Gene Therapy Market Share by Type: 2022 VS 2033
Figure 3. Synovium Injection Features
Figure 4. Cartilage Injection Features
Figure 5. Global Osteoarthritis Gene Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Osteoarthritis Gene Therapy Market Share by Application: 2022 VS 2033
Figure 7. Hospitals and clinics Case Studies
Figure 8. Orthopedic Centers Case Studies
Figure 9. Assisted living Facilities Case Studies
Figure 10. Nursing Homes Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Others Case Studies
Figure 13. Osteoarthritis Gene Therapy Report Years Considered
Figure 14. Global Osteoarthritis Gene Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Osteoarthritis Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Osteoarthritis Gene Therapy Market Share by Region: 2022 VS 2033
Figure 17. Global Osteoarthritis Gene Therapy Market Share by Players in 2022
Figure 18. Global Top Osteoarthritis Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Gene Therapy as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Osteoarthritis Gene Therapy Revenue in 2022
Figure 20. North America Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Osteoarthritis Gene Therapy Market Share by Country (2018-2033)
Figure 22. United States Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Osteoarthritis Gene Therapy Market Share by Country (2018-2033)
Figure 26. Germany Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Osteoarthritis Gene Therapy Market Share by Region (2018-2033)
Figure 34. China Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Osteoarthritis Gene Therapy Market Share by Country (2018-2033)
Figure 42. Mexico Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Osteoarthritis Gene Therapy Market Share by Country (2018-2033)
Figure 46. Turkey Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Osteoarthritis Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Flexion Revenue Growth Rate in Osteoarthritis Gene Therapy Business (2018-2023)
Figure 49. GeneQuine Revenue Growth Rate in Osteoarthritis Gene Therapy Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in Osteoarthritis Gene Therapy Business (2018-2023)
Figure 51. Smith & Nephew Revenue Growth Rate in Osteoarthritis Gene Therapy Business (2018-2023)
Figure 52. Genascence Revenue Growth Rate in Osteoarthritis Gene Therapy Business (2018-2023)
Figure 53. Kolon TissueGene Revenue Growth Rate in Osteoarthritis Gene Therapy Business (2018-2023)
Figure 54. Sanofi Revenue Growth Rate in Osteoarthritis Gene Therapy Business (2018-2023)
Figure 55. Paraxel Revenue Growth Rate in Osteoarthritis Gene Therapy Business (2018-2023)
Figure 56. Medipost Revenue Growth Rate in Osteoarthritis Gene Therapy Business (2018-2023)
Figure 57. Mundipharma Revenue Growth Rate in Osteoarthritis Gene Therapy Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed